BioMarin Pharmaceutical(BMRN) - 2024 Q4 - Earnings Call Presentation

Fourth Quarter 2024 Earnings February 19, 2025 BioMarin regularly uses both GAAP and Non-GAAP results and expectations internally to assess its financial operating performance and evaluate key business decisions related to its principal business activities: the discovery, development, manufacture, marketing and sale of innovative biologic therapies. Because Non- GAAP Income, Non-GAAP Operating Margin percentage, Non-GAAP Diluted EPS, and Non-GAAP Weighted-Average Diluted Shares Outstanding are important int ...